Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CONESTAT ALFA for Immunodeficiency: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where CONESTAT ALFA was used for Immunodeficiency.

Most Reported Side Effects for CONESTAT ALFA

Side Effect Reports % Deaths Hosp.
Intentional product use issue 227 15.1% 2 35
Condition aggravated 166 11.0% 2 23
Weight fluctuation 125 8.3% 0 8
Product use in unapproved indication 97 6.5% 0 15
Drug ineffective 94 6.3% 0 45
Vascular access site complication 90 6.0% 0 5
Underdose 74 4.9% 0 10
Weight decreased 74 4.9% 0 17
Weight increased 74 4.9% 0 11
Insurance issue 48 3.2% 0 8
Product dose omission issue 46 3.1% 0 10
Stress 45 3.0% 0 5
Maternal exposure during pregnancy 34 2.3% 3 9
Dyspnoea 33 2.2% 0 26
Covid-19 30 2.0% 0 7

Other Indications for CONESTAT ALFA

Hereditary angioedema (1,385) Product used for unknown indication (55) Hereditary angioedema with normal c1 esterase inhibitor (39) Hereditary angioedema with c1 esterase inhibitor deficiency (12) Immunodeficiency common variable (7) Angioedema (6) Immune system disorder (6)

Other Drugs Used for Immunodeficiency

HUMAN IMMUNOGLOBULIN G (2,648) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (404) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (224) CILGAVIMAB\TIXAGEVIMAB (76) DUPILUMAB (55) METRONIDAZOLE (35) MEROPENEM (28) VALACYCLOVIR (26) TOCILIZUMAB (24) ABATACEPT (23)

Related Pages

CONESTAT ALFA Full Profile All Immunodeficiency Drugs CONESTAT ALFA Demographics CONESTAT ALFA Timeline